---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-046891"
form_type: "8-K"
ticker: "CTKB"
cik: "0001831915"
company_name: "Cytek Biosciences, Inc."
filed_at: "2024-02-27T23:59:59+00:00"
generated_at: "2026-06-05T12:47:01.077024+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Cytek Biosciences amends severance plan; CEO gets 12-month base, 24-month on change of control

## Summary
- Compensation Committee approved Second Amended and Restated Severance Benefit Plan effective Feb 20, 2024.
- Non-CIC termination: CEO receives 12 months base salary + COBRA; other NEOs get 9 months base + COBRA.
- CIC termination: CEO receives 24 months base salary + 100% target bonus + 24 months COBRA + full equity vesting.
- Other NEOs get 18 months base salary + 100% target bonus + 18 months COBRA + full equity vesting.
- Benefits require signed release and compliance with restrictive covenants.

## SEC filing metadata
- accession: 0001193125-24-046891
- form_type: 8-K
- ticker: CTKB
- cik: 0001831915
- company_name: Cytek Biosciences, Inc.
- filed_at: 2024-02-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831915/000119312524046891/0001193125-24-046891-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831915/000119312524046891/d755593d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-046891
- JSON: https://secwatch.observer/filing/0001193125-24-046891.json
- Plain text: https://secwatch.observer/filing/0001193125-24-046891.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.